Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis.

Rousset S, Treiner E, Moulis G, Pugnet G, Astudillo L, Paricaud K, Puissant-Lubrano B, Arlet P, Blancher A, Sailler L.

Rheumatology (Oxford). 2019 Sep 13. pii: kez390. doi: 10.1093/rheumatology/kez390. [Epub ahead of print]


Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.

Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, Delobel P, Liblau R, Martin-Blondel G; Immune Checkpoint Inhibitors in PML Study Group.

N Engl J Med. 2019 Apr 25;380(17):1674-1676. doi: 10.1056/NEJMc1816198. Epub 2019 Apr 10. No abstract available.


Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients.

Zabijak L, Attencourt C, Guignant C, Chatelain D, Marcelo P, Marolleau JP, Treiner E.

Cancer Immunol Immunother. 2015 Dec;64(12):1601-8. doi: 10.1007/s00262-015-1764-7. Epub 2015 Oct 23.


Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out.

Treiner E, Liblau RS.

Front Immunol. 2015 Sep 30;6:503. doi: 10.3389/fimmu.2015.00503. eCollection 2015. Review.


Mucosal-associated invariant T cells in inflammatory bowel diseases: bystanders, defenders, or offenders?

Treiner E.

Front Immunol. 2015 Feb 2;6:27. doi: 10.3389/fimmu.2015.00027. eCollection 2015. Review. No abstract available.


The importance of EN ISO 15189 accreditation of allergen-specific IgE determination for reliable in vitro allergy diagnosis.

Lambert C, Sarrat A, Bienvenu F, Brabant S, Nicaise-Roland P, Alyanakian MA, Apoil PA, Capron C, Couderc R, Evrard B, Jaby D, Hémont C, Lainé C, Lelong M, Mariotte D, Martinet J, Rénier G, Sainte-Laudy J, Tabary T, Treiner E, Uring-Lambert B, Vigneron C, Vivinus M, Witthuhn F, Vitte J; AllergoBioNet sIgE accreditation interest group.

Allergy. 2015 Feb;70(2):180-6. doi: 10.1111/all.12546.


Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.

Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P, Chatelain D, Barre A, Nguyen-Khac E, Lantz O, Dupas JL, Treiner E.

Clin Exp Immunol. 2014 May;176(2):266-74. doi: 10.1111/cei.12277.


MAIT cells detect and efficiently lyse bacterially-infected epithelial cells.

Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V, Coré M, Sleurs D, Serriari NE, Treiner E, Hivroz C, Sansonetti P, Gougeon ML, Soudais C, Lantz O.

PLoS Pathog. 2013;9(10):e1003681. doi: 10.1371/journal.ppat.1003681. Epub 2013 Oct 10.


MR1B, a natural spliced isoform of the MHC-related 1 protein, is expressed as homodimers at the cell surface and activates MAIT cells.

Lion J, Debuysscher V, Wlodarczyk A, Hodroge A, Serriari NE, Choteau L, Ouled-haddou H, Plistat M, Lassoued K, Lantz O, Treiner E.

Eur J Immunol. 2013 May;43(5):1363-73. doi: 10.1002/eji.201242461.


Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells.

Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D, Milder M, Le Bourhis L, Soudais C, Treiner E, Lantz O.

Blood. 2011 Jan 27;117(4):1250-9. doi: 10.1182/blood-2010-08-303339. Epub 2010 Nov 17.


NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model.

Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH.

J Immunol. 2009 Apr 15;182(8):4572-80. doi: 10.4049/jimmunol.0803900.


Stepwise development of MAIT cells in mouse and human.

Martin E, Treiner E, Duban L, Guerri L, Laude H, Toly C, Premel V, Devys A, Moura IC, Tilloy F, Cherif S, Vera G, Latour S, Soudais C, Lantz O.

PLoS Biol. 2009 Mar 10;7(3):e54. doi: 10.1371/journal.pbio.1000054.


CD1d- and MR1-restricted invariant T cells: of mice and men.

Treiner E, Lantz O.

Curr Opin Immunol. 2006 Oct;18(5):519-26. Epub 2006 Jul 25. Review.


Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset.

Treiner E, Duban L, Moura IC, Hansen T, Gilfillan S, Lantz O.

Microbes Infect. 2005 Mar;7(3):552-9. Epub 2005 Feb 12. Review.


A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH.

Blood. 2005 Jun 1;105(11):4416-23. Epub 2005 Feb 22.


[MAIT lymphocytes, regulators of intestinal immunity?].

Treiner E.

Presse Med. 2003 Oct 25;32(35):1636-7. French. No abstract available.


Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1.

Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, Affaticati P, Gilfillan S, Lantz O.

Nature. 2003 Mar 13;422(6928):164-9. Erratum in: Nature. 2003 Jun 26;423(6943):1018.


An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals.

Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H, Bendelac A, Bonneville M, Lantz O.

J Exp Med. 1999 Jun 21;189(12):1907-21.

Supplemental Content

Loading ...
Support Center